Jpmorgan Chase & CO Veracyte, Inc. Transaction History

Jpmorgan Chase & CO

$1.22 Trillion
Q3 2024

A detailed history of Jpmorgan Chase & CO transactions in Veracyte, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 346,587 shares of VCYT stock, worth $13.7 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

346,587

Previous 349,130 0.73%

Holding current value

$13.7 Million

Previous $7.57 Million 55.9%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$21.0 - $35.25 $53,403 - $89,640	-2,543 Reduced 0.73%	346,587 $11.8 Million
Q2 2024 Aug 12, 2024	BUY	$18.86 - $23.55 $5.06 Million - $6.32 Million	268,466 Added 332.82%	349,130 $7.57 Million
Q1 2024 May 10, 2024	SELL	$21.0 - $29.1 $768,159 - $1.06 Million	-36,579 Reduced 31.2%	80,664 $1.79 Million
Q4 2023 Feb 12, 2024	SELL	$19.72 - $28.68 $2.83 Million - $4.12 Million	-143,623 Reduced 55.06%	117,243 $3.23 Million
Q3 2023 Nov 14, 2023	SELL	$22.33 - $29.92 $180,046 - $241,244	-8,063 Reduced 3.0%	260,866 $5.83 Million
Q2 2023 Aug 11, 2023	BUY	$20.96 - $26.99 $3.69 Million - $4.76 Million	176,275 Added 190.25%	268,929 $6.85 Million
Q1 2023 May 18, 2023	BUY	$20.58 - $27.89 $1.85 Million - $2.51 Million	90,034 Added 3436.41%	92,654 $2.07 Million
Q1 2023 May 11, 2023	SELL	$20.58 - $27.89 $7.88 Million - $10.7 Million	-382,829 Reduced 99.32%	2,620 $58,000
Q4 2022 Feb 13, 2023	BUY	$15.31 - $29.94 $937,125 - $1.83 Million	61,210 Added 18.88%	385,449 $9.15 Million
Q3 2022 Nov 14, 2022	BUY	$16.58 - $27.9 $4.26 Million - $7.17 Million	256,867 Added 381.27%	324,239 $5.38 Million
Q2 2022 Aug 11, 2022	BUY	$15.45 - $29.52 $186,203 - $355,775	12,052 Added 21.79%	67,372 $1.34 Million
Q1 2022 May 11, 2022	BUY	$21.94 - $42.51 $210,382 - $407,628	9,589 Added 20.97%	55,320 $1.53 Million
Q4 2021 Feb 10, 2022	BUY	$36.09 - $53.79 $75,572 - $112,636	2,094 Added 4.8%	45,731 $1.88 Million
Q3 2021 Nov 12, 2021	BUY	$35.62 - $52.97 $1.55 Million - $2.31 Million	43,637 New	43,637 $2.03 Million

Others Institutions Holding VCYT

# of Institutions

308

Shares Held

81.8M

Call Options Held

134K

Put Options Held

13.3K

View Full List

About VERACYTE, INC.

Ticker VCYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,575,904
Market Cap $2.83B
Description
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...

More about VCYT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Veracyte, Inc. Transaction History